Biosimilars Market Analysis - Global Industry Size, Share, Trends and Forecast, 2014 - 2024

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC261

A biosimilar, also known as subsequent entry biologic or follow-on biologic, is a medical product (drug) that is almost a similar or identical copy of the original product which is manufactured by some other company. These products are legitimately permitted versions of the original innovator products. They are generally manufactured when the patent of original product of the parent company expires. The key factors propelling the growth of biosimilars market include the continuous increase in pressure to reduce healthcare expenditure, growing incidences of several diseases, increasing demand for biosimilars owing to their cost-effectiveness, helpful effects in the current clinical trials, growing number of off-patented drugs, and growing biosimilars demand in various therapeutic applications including blood disorders and rheumatoid arthritis. However, factors restricting the global biosimilars demand are strict regulatory requirements in different countries, high manufacturing costs and complexities and innovative strategies applied by various biosimilar drug manufacturers to limit the entry of new players. 
 
The global biosimilar market is segmented based on product type, applications, technology, services and geography. The product segment of biosimilar market is further sub-segmented into recombinant non-glycosylated proteins, recombinant peptides and recombinant glycosylated proteins. Furthermore,the recombinant non-glycosylated proteins market is sub-segmented into granulocyte colony-stimulating factor insulin, human growth hormone and interferons. Also, recombinant glycosylated proteins are sub-segmented into monoclonal antibodies, follitropin and erythropoietin. On the basis of applications, the market is classified by blood disorders, growth hormone deficiency, oncology, chronic & autoimmune diseases and other applications. Oncology application segment in biosimilar market is leading due to introduction of new biosimilars whereas, chronic & autoimmune disorders is anticipated to grow in the coming years owing to the growing cases of autoimmune diseases such as psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. 
 
Further, technology segment is bifurcated into monoclonal antibodies technology, chromatography, electrophoresis, recombinant DNA technology, western blotting, nuclear magnetic resonance technology, bioassay and mass spectrometry. By services, the market is segmented into clinical trials and contract research & manufacturing services. Geographically, the market is bifurcated into North America, Asia-Pacific, Europe, Latin America, and Middle East, and Africa. 
 
Developing economies offer substantial opportunities to the manufacturers of biosimilar products. However, the global market is anticipated to face a major challenge regarding the complex infrastructure production requirements for the biosimilars and the need to obtain approval from regulatory bodies for the rigorous clinical trials. Europe is expected to dominate the biosimilars market followed by Asia-Pacific. The growth in Europe is anticipated to grow owing to the pressure for reduction in healthcare costs, introduction of new biosimilar products, biologic products patent expiry, growing incidences of chronic diseases such as diabetes and cancer; and entry of new emerging biosimilar players in the market. 
 
Asia-Pacific’s growth is attributed to the developing infrastructure of healthcare, rising investments in biosimilars development, huge patient population in the region and rising focus on international as well as domestic players in the Asia-Pacific region. Also, the government authorities in Asia-Pacific are focusing on promoting the use of biosimilars in order to decrease their burden towards healthcare expenses, thus providing growth opportunities to the manufacturers of biosimilars. This is backed by favorable and sound support through reimbursements related to commercialization and research; and effective regulations for biosimilar drugs. Also, the companies in developing regions are adopting alliance or collaboration strategies with key players in the developed economies in order to sustain in the market.
 
The key players operating in the biosimilars market include Hospira, Inc., Teva Pharmaceutical Industries Ltd., Roche Diagnostics, Sandoz International GmbH, Biocon Ltd., Amgen, Dr. Reddy's Laboratories, Mylan, Inc., Celltrion, Inc. and Merck KGAA among others.
 


Related Reports

Behavioral Health Market (By Disorder: Alcohol Use Disorders, Schizophrenia, Bipolar Disorder, Depression, Anxiety, Post-traumatic Stress Disorder, Substance Abuse Disorders, Eating Disorders, Others; By Service: Emergency Mental Health Services, Outpatient Counselling, Home-based Treatment Services, Inpatient Hospital Treatment Services, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Behavioral Health market is forecasted to grow at striking CAGR around 2.5 % over the forecast time frame and reach around US$ 240 billion by 2026. Behavioural health involves non-pharmacological therapies for circumstances like mental health, drug abuse disorder, etc. Due to mental illnesses,

Transcranial Magnetic Stimulator Market (By Type: dTMS, rTMS, Others; By Application: Depression, Epilepsy) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026Transcranial Magnetic Stimulator Market (By Type: dTMS, rTMS, Others; By Application: Depression, Epilepsy) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global transcranial magnetic stimulator market size is accounted over USD 2.1 Billion by 2026 and growing at CAGR 9.0% during the forecast period 2019-2026. Transcranial magnetic stimulators are widely used in the treatment of brain and neurological diseases. The transcranial magnetic stimulators is a non-invasive technique which applies magnetic pulses to the brain that uses magnetic field to reduce chronic pain and stimu

Sacral Nerve Stimulation Market (By Product: Implantable, External; By Application: Urinary & Fecal Incontinence, Urge Incontinence, Chronic Anal Fissure, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global sacral nerve stimulation market size is expected to reach over 2.3 USD billion by 2026 at the CAGR 12.1% during the forecast period, 2019-2026. A Sacral nerve stimulation is implanted as a device to control bladder functions by delivering controlled electrical impulses to the sacral nerves that modulate the neural pathways. It is an effective and safe treatment for patients suffering fro

Medical Imaging Workstations Market (By Modality: Computed Tomography, MRI, X-ray; By Component: Visualization Software, Display Units; By Usage Mode: Thin, Thick; By Application: Diagnostic Imaging, Clinical Review; By End User: Hospital and Clinics, Diagnostics Centers, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global market for Medical Imaging Workstations is estimated to grow at a significant rate of 8.5% during the forecasted period and is expected to reach over 2.3 billion by 2026. Medical imaging workstations are used in the hospitals while setting up the equipments. During last few years there is an significant increase in the prevalence of the various diseases and accidents which has increased

Laser Hair Removal Market (End User: Dermatology Clinics, Beauty Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global laser hair removal market value is accounted over USD 3.9 Billion by 2026 and is expected to grow at CAGR 15.4% during the forecast period 2019-2026. The global laser hair removal product market is driven by increased awareness regarding personal appearance and rising health awareness among the population. Additionally, improved standard of living and rising disposable income tremendously affects the laser hair remo

Idiopathic Pulmonary Fibrosis Treatment Market (By Drug Class: Tyrosine Inhibitors, MAPK Inhibitors, Autotaxin Inhibitors; By End User: Hospitals, Long-term Care Facilities, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global Idiopathic Pulmonary Fibrosis Treatment Market is expected to reach over 4.2 USD billion by 2026 and growing at CAGR 11.6% during the forecast period 2019-2026. During last few years, there is a significant increase in the number of respiratory related diseases. Increasing prevalence of the various respiratory diseases, rising geriatric population across the globe, and increasing awareness about health have driven t

Cart Summary